Potential impact of interventions to reduce times to thrombolysis

Emergency Medicine Journal

Volumn 21, Issue 5, 2004, Pages 625-629

  Goodacre, S ^a   Kelly, A M ^b   Kerr, D ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Joseph Epstein Centre for Emergency Medicine Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGE; AGED; AMBULANCE; ARTICLE; AUSTRALIA; BLOOD CLOT LYSIS; CLINICAL OBSERVATION; CONTROLLED STUDY; DATA ANALYSIS; EMERGENCY TREATMENT; FEMALE; GENDER; GENERAL PRACTITIONER; HEART INFARCTION; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORTALITY; PATIENT COUNSELING; PATIENT REFERRAL; PATIENT TRANSPORT; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RURAL AREA; SYMPTOMATOLOGY; TIME MANAGEMENT; TREATMENT OUTCOME; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; AMBULANCES; DRUG ADMINISTRATION SCHEDULE; EMERGENCY MEDICAL SERVICE COMMUNICATION SYSTEMS; EMERGENCY MEDICAL SERVICES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; THROMBOLYTIC THERAPY; TIME FACTORS; VICTORIA;

EID: 4544225570     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2003.012575     Document Type: Article

References (17)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised controlled trials of more than 1000 patients. Lancet 1994;343:311-22.
2. Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5.
3. Kelly A-M, Kerr D, Patrick I, et al. Call to needle times for thrombolysis in acute myocardial infarction in Victoria. Med J Aust 2003;178:381-5.
4. Millar-Craig MW, Joy AV, Adamowicz M, et al. Reduction in treatment delay by paramedic ECG diagnosis of myocardial infarction with direct CCU admission. Heart 1997;78:456-61.
5. Hourigan CT, Mountain D, Langton PE, et al. Changing the site of delivery of thrombolytic treatment for acute myocardial infarction from the coronary care unit to the emergency department greatly reduces door to needle time. Heart 2000;84:573-4.
6. Morrison LJ, Verbeek PR, McDonald AC, et al. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA 2000;238:2686-92.
7. Department of Health. The National Service Framework for coronary heart disease. London: Department of Health, 2000.
8. Banerjee S, Rhoden WE. Fast-tracking of myocardial infarction by paramedics. J R Coll Physicians Lond 1998;32:36-8.
9. Bryant M, Kelly AM. "Point of entry" treatment gives best time to thrombolysis for acute myocardial infarction. Aust Health Rev 2001;24:157-60.
10. Edhouse JA, Sakr M, Wardrope J, et al. Thrombolysis in acute myocardial infarction: the safety and efficiency of treatment in the accident and emergency department. J Accid Emerg Med 1999;16:325-30.
11. Birkhead JS. Trends in the provision of thrombolytic treatment between 1993 and 1997. Myocardial Infarction Audit Group. Heart 1999;82:438-42.
12. Department of Health. NHS Direct. London: Department of Health, 2003.
13. Pitt K. Prehospital selection of patients for thrombolysis by paramedics. Emerg Med J 2002;19:260-3.
14. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy: the Myocardial Infarction Triage and Intervention Trial. JAMA 1993;270:1211-16.
15. The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993;329:383-9.
16. GREAT group. Feasibility, safety, and efficacy of domicillary thrombolysis by general practitioners: Grampian Region Early Anistreplase Trial. BMJ 1992;305:548-53.
17. Boland A, Dundar Y, Bagust A, et al. Early thrombolysis for the treatment of acute myocardial infarction: a rapid and systematic review. Health Technol Assess (in press). (Accessed via the National Institute for Clinical Excellence web site http://www.nice.org.uk/).